Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis

Overview of attention for article published in Nature Medicine, July 2011

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (96th percentile)
High Attention Score compared to outputs of the same age and source (93rd percentile)

Mentioned by

blogs: 3 blogs
twitter: 12 X users
patent: 7 patents

wikipedia: 3 Wikipedia pages
googleplus: 1 Google+ user
f1000: 1 research highlight platform

Readers on

mendeley: 357 Mendeley
citeulike: 2 CiteULike
connotea: 1 Connotea

So far, Altmetric has seen 14 X posts from 12 X users, with an upper bound of 98,861 followers.

9 years later, through studies exceeding analyses in tens of thousands of patients have validated that suPAR high risk plasma cut off is 3000pg/ml. That is the same level Wei et al. have proposed in the Nature Medicine paper in 2011. ⁦@salimhayek⁩ https…

suPAR was first identified as a risk factor in 2011 by @JochenReiser and colleagues: https://t.co/QYTVNNjhZx #KidneyWk

Reiser is well known for his work identifying soluble urokinase receptor as a circulating factor present in a cohort of patients w FSGS. https://t.co/QbGAqNGCHD #kidneywk

RT @Wagner_Nephro: Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis. https://t.co/L84fUytZPm

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 10 additional X posts.